Superficial mycosis, unspecified
ICD-10 B36.9 is a billable code used to indicate a diagnosis of superficial mycosis, unspecified.
Superficial mycosis refers to a group of fungal infections that primarily affect the outer layers of the skin, hair, and nails. These infections are typically caused by dermatophytes, yeasts, or non-dermatophyte molds. Common manifestations include tinea (ringworm), candidiasis, and other fungal skin infections. The term 'unspecified' indicates that the specific type of superficial mycosis has not been identified or documented. Patients may present with symptoms such as itching, redness, scaling, and lesions on the skin or nails. Diagnosis is often made through clinical examination and may be supported by laboratory tests, including KOH preparations or fungal cultures. Treatment typically involves topical or systemic antifungal agents, depending on the severity and extent of the infection. In immunocompromised patients, such as those with HIV/AIDS, diabetes, or undergoing chemotherapy, the risk of superficial mycosis increases, and infections may be more severe or resistant to standard treatments. Therefore, careful management and monitoring are essential in these populations.
Detailed clinical notes describing the lesion characteristics, location, and any diagnostic tests performed.
Diagnosis and treatment of tinea corporis, tinea pedis, and candidiasis.
Ensure to document any underlying conditions that may predispose the patient to fungal infections.
Comprehensive patient history, including immunocompromised status and previous infections.
Management of recurrent fungal infections in immunocompromised patients.
Consideration of systemic antifungal therapy and monitoring for drug interactions.
Used when a fungal infection is suspected and a culture is taken.
Document the site of culture and clinical suspicion of fungal infection.
Dermatology and Infectious Disease specialists should ensure cultures are properly labeled and processed.
Use B36.9 when the specific type of superficial mycosis is not documented or confirmed. Ensure that all clinical details are captured to support this coding choice.
